• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameHANCOCK MODIFIED ORIFICE II AORTIC BIOPROSTHESIS
Classification Nameheart-valve, non-allograft tissue
Generic Nameheart valve
ApplicantTHE HEART VALVE DIV. MEDTRONIC CARDIOVASCULAR SURG
PMA NumberP790007
Supplement NumberS013
Date Received05/13/1996
Decision Date12/10/1996
Product Code
LWR[ Registered Establishments with LWR ]
Advisory Committee Cardiovascular
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications - other
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for two add'l styles (type f and type g) of the model 250 valve. The device, as modified, will be marketed under the trade names hancock(r) modified orifice ii aortic bioprosthesis, model 250, extended supra-annular flange (type f) and hancock(r) modified orifice ii aortic bioprosthesis, model 250, supra-annular flange (type g). The indication for use and available sizes (19, 21, 23, and 25 mm) for the mdoel 250 valves have not changed.
-
-